Evidence map›Paper›PMID 42518841›Full record

ArticlePractical laboratory medicine2026

Aberrant peripheral blood CD34

Itsuko Miyazawa, Junko Okano, Natsuko Ohashi, Kazunori Fujino, Miwako Katagi, Shinji Kume, Hideto Kojima

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Practical laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Itsuko MiyazawaDepartment of Medicine, Shiga University of Medical Science, Japan.
Junko OkanoDepartment of Plastic and Reconstructive Surgery, Shiga University of Medical Science, Japan.
Natsuko OhashiDepartment of Medicine, Shiga University of Medical Science, Japan.
Kazunori FujinoDepartment of Critical and Intensive Care Medicine, Shiga University of Medical Science, Japan.
Miwako KatagiDepartment of Biocommunication Development, Shiga University of Medical Science, Japan.
Shinji KumeDepartment of Medicine, Shiga University of Medical Science, Japan.
Hideto KojimaDepartment of Biocommunication Development, Shiga University of Medical Science, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HbA1c and blood glucose (BS) are routinely used in diabetic care, but they do not provide direct information about ongoing cellular pathogenic processes. Previous studies in diabetic animal models identified a CD106

Indexed as

Bone marrowCD106+ TNFα+ proinsulin+ CD34+ subsetCellular biomarkerDiabetic stem cellHbA1cType 2 diabetes mellitus

Identifiers

PMID42518841
PMCPMC13382448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.